Deltagen Inc.
Other OTCTotal Valuation
Deltagen Inc. carries a market capitalization of 3,859.00, placing it among publicly traded companies globally. Its enterprise value stands at 9.88M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 3,859.00 |
| Enterprise Value | 9.88M |
Valuation Ratios
Deltagen Inc. trades at a trailing price-to-earnings ratio of 6.43. The price-to-sales ratio is 2.45, and the price-to-book ratio stands at -0.06.
| PE Ratio | 6.43 |
| PS Ratio | 2.45 |
| PB Ratio | -0.06 |
| P/TBV Ratio | 2.03 |
| P/FCF Ratio | -36.59 |
| P/OCF Ratio | -36.59 |
Enterprise Valuation
On an enterprise value basis, Deltagen Inc. trades at an EV/EBITDA multiple of 16.14 and an EV/FCF ratio of 13.45. The EV/Sales ratio of 1.93 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 17.24 provides insight into valuation relative to core operating earnings.
| EV / Sales | 1.93 |
| EV / EBITDA | 16.14 |
| EV / EBIT | 17.24 |
| EV / FCF | 13.45 |
Financial Position
Deltagen Inc. maintains a current ratio of 11.39, meaning it holds 11.4x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 11.39 |
| Quick Ratio | 8.95 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | 23.89 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | 7.76 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Taxes
| Income Tax | -251,000.00 |
| Effective Tax Rate | N/A |
Stock Price Statistics
Deltagen Inc.'s stock has gained approximately 0.000003% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.00.
| Beta (5Y) | N/A |
| 52-Week Price Change | 0.000003% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.00 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Deltagen Inc. generated 5.12M in revenue and converted that into 1.95M in net income, yielding earnings per share of 0.05. EBITDA reached 612,000.00, while operating income came in at 573,000.00.
| Revenue | 5.12M |
| Gross Profit | N/A |
| Operating Income | 573,000.00 |
| Pretax Income | 913,000.00 |
| Net Income | 1.95M |
| EBITDA | 612,000.00 |
| EBIT | 573,000.00 |
| Earnings Per Share (EPS) | 0.05 |
Balance Sheet
Total book value stands at -222.62M, with working capital of 5.09M providing operational flexibility.
| Cash & Cash Equivalents | 2.67M |
| Total Debt | N/A |
| Net Debt | -2.67M |
| Equity (Book Value) | -222.62M |
| Book Value Per Share | -5.68 |
| Working Capital | 5.09M |
Cash Flow
Deltagen Inc. produced -343,000.00 in operating cash flow over the past twelve months.
| Operating Cash Flow | -343,000.00 |
| Capital Expenditures | N/A |
| Free Cash Flow | -343,000.00 |
| FCF Per Share | -0.01 |
Margins
Deltagen Inc. operates with a gross margin of 100.00, reflecting its pricing power and cost economics. The operating margin of 11.18 and net profit margin of 38.08 provide insight into operational efficiency.
| Gross Margin | 100.00 |
| Operating Margin | 11.18 |
| Pretax Margin | 17.82 |
| Profit Margin | 38.08 |
| EBITDA Margin | 11.94 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 61.50 |
| FCF Yield | -2.73 |
Scores
Deltagen Inc. posts an Altman Z-Score of -29.43, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -29.43 |